The medical community increasingly recognizes chronic inflammation as a fundamental driver behind numerous health conditions, from obvious manifestations like rheumatoid arthritis and inflammatory ...

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key ...

A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics ...

The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.

It’s becoming more common to treat Crohn’s disease with 2 biologic medications, or a biologic and a small molecule drug. Find out how it works, and who might try it.

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients. New research led by ...

The findings suggest that dampening eosinophilic and T2 inflammatory responses result in increases in several alternative inflammatory pathways that contribute to residual exacerbations in children ...

A massive single-cell study has revealed hidden genetic differences in male and female immune systems that may shape disease ...